Presence of Strong Drug Pipeline to Create Promising Growth Opportunities for Global Osteoarthritis Market

Published Date : Mar 06, 2017

ALBANY, New York, March 06, 2017: A research study has been added recently by to its massive repository of market intelligence reports. The 207-page research study, titled “Opportunity Analyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024,” offers a detailed reports of the global osteoarthritis market and throws light on growth opportunities for the key players in the next few years. The overview of the osteoarthritis market, focusing on the etiology, epidemiology, symptoms, pathophysiology, diagnosis, and treatment guidelines. With the help of analytical tools, the current trends, drivers, and potential opportunities in the global market have been highlighted in the study. 

Furthermore, the market characterization, strategic competitor assessment, clinical trial mapping, and unmet needs of the global osteoarthritis market have been provided in the research study in order to guide the players operating in the market. In addition, a detailed reports of the drug pipeline of osteoarthritis has been profiled in the research report. Insightful inputs of the market drivers, barriers, and limitations have been offered for qualitative reports of its implications. 

The rising incidences of surgeries and the growing focus on technological advancements are some of the prominent factors are anticipated to encourage the growth of the global osteoarthritis market in the forecast period. The rising number of drugs in the pipeline and the growing awareness among patients concerning healthcare are expected to accelerate the growth of the market in the near future. In addition, the growing spending capacity of consumers, especially in emerging nations is likely to contribute towards the growth of the market in the near future. On the flip side, the less adoption of the osteoarthritis treatment and stringent regulatory framework are projected to restrict the growth of the global market in the near future. 

For Sample Copy, click here: 

The availability of advanced healthcare infrastructure and the rising prevalence of osteoarthritis in developed economies is fuelling the growth of the Europe and North America markets. Moreover, the rising access to health care insurance is estimated to supplement the growth of these two regions in the coming years. On the other hand, Asia Pacific is likely to exhibit a healthy growth rate throughout the forecast period. The presence of a large pool of patients is one of the key factors augmenting the osteoarthritis market in Asia Pacific. 

Some of the key players operating in the global osteoarthritis market are Merck, Novartis, Pfizer, Nuvo Research, Regeneus, Sanofi, Daiichi Sankyo, Eli Lilly, Iroko Pharmaceuticals, Abbott Laboratories, SantoSolve, Johnson & Johnson, Horizon Pharma, and Abiogen Pharma. These players are making efforts to expand their drug pipeline and introduce effective devices that will encourage the growth of the overall market in the near future. As per the research study, several new players are anticipated to enter the global osteoarthritis market, owing to which the competitive scenario is predicted to get intense in the next few years. 

To order report Call Toll Free: 866-997-4948 or send an email on